First Sound Pharmaceuticals Class 1 new drug "Idala feng right-handed 莰 alcohol injection" will soon be approved.

On July 24, the application for listing of Aydara, a class 1 new drug submitted by First Sound Dongyuan Pharmaceuticals, entered the "in approval" stage of applying for right-handedalcohol injection (Idala fufu compound preparation), which is expected to be approved in the near future for the treatment of ischemic stroke.the pronoun pharmaceutical prospectus shows that Idalafeng rightalcohol injection is an innovative neuroprotective agent, with a 4:1 ratio combination of two active ingredients Idarafon and right- alcohol, the use of two ingredients to remove free radicals, anti-inflammatory and improve the hemophilia barrier and other multiple mechanisms, can significantly reduce and improve acute ischemic encephalopathy caused by nerve damage.Idarala rightalcohol injection is an upgraded variety of acute ischemic stroke drug Idarala injection (mandatory).a random, double-blind, positive control, head-to-head comparison of 1,200 patients with acute ischemic stroke showed that, in contrast to the unilateral Idadara injection, Idala's rightalcohol injection showed clear efficacy advantages, similar clinical safety, and significantly extended the existing treatment window from 24 hours to 48 hours.,""da'er has become the largest cause of death and disability among adults in China, with a high recurrence rate and a severe lack of more effective treatment, according to the.S. Frost Sullivan. sales of-sounding pharmaceutical company Idala finjectionin in 2017, 2018 and 21019 were RMB12.44, RMB1199 and RMB937 million, respectively.accounts for about 36.8 percent of China's Idalafon drug market in terms of 2019 sales..